Role of optical coherence tomography in depression detection: a protocol of systematic review and meta-analysis

被引:1
作者
Xiao, Xili [1 ]
Zhong, Dongling [2 ]
Liu, Huan [3 ]
Fan, Rong [3 ]
Jiang, Chengzhi [4 ]
Zheng, Zhong [5 ]
Li, Yuxi [2 ]
Wan, Li [6 ]
机构
[1] Hosp Chengdu Univ Tradit Chinese Med, Dept Ophthalmol, Chengdu, Peoples R China
[2] Chengdu Univ Tradit Chinese Med, Sch Hlth Preservat & Rehabil, Chengdu, Peoples R China
[3] Nanbu Cty Peoples Hosp, Dept Rehabil Med, Nanchong, Peoples R China
[4] Sichuan Sci City Hosp, Dept Rehabil Med, Mianyang, Peoples R China
[5] Sichuan Univ, Mental Hlth Ctr, West China Hosp, Chengdu, Peoples R China
[6] Chengdu Sport Univ, Sch sports Med & Hlth, Chengdu, Peoples R China
来源
BMJ OPEN | 2023年 / 13卷 / 07期
关键词
depression & mood disorders; neuro-ophthalmology; ophthalmology; systematic review; protocols & guidelines; FIBER LAYER THICKNESS; ABNORMALITIES; DISORDER; GRAY; TOOL; EYE;
D O I
10.1136/bmjopen-2022-065549
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
IntroductionOptical coherence tomography (OCT) is a non-invasive approach for detecting changes in the retinal layers, which may also reflect changes in brain structure and function. As one of the leading causes of disability worldwide, depression has been associated with alteration of brain neuroplasticity. However, the role of OCT measurements in detecting depression remains unknown. This study aims to employ a systematic review and meta-analysis approach to explore ocular biomarkers measured by OCT for detecting depression. Methods and analysisWe will search studies describing the relationship between OCT and depression across seven electronic databases, and retrieve articles published from database inception to date. We will also manually search grey literature and reference lists included in the retrieved studies. Two independent reviewers will screen studies, extract data and assess risk of bias. Target outcomes will include peripapillary retinal nerve fibre layer thickness, macular ganglion cell complex thickness and macular volume, as well as other related indicators. Next, we will conduct subgroup analysis and meta-regression to explore study heterogeneity, then perform sensitivity analysis to investigate the robustness of the synthesised results. Meta-analysis will be performed using Review Manager (V.5.4.1) and STATA (V.12.0), and the certainty of evidence will be graded according to the Grading of Recommendations Assessment, Development and Evaluation system. Ethics and disseminationEthics approval is not necessary because the data used in this systematic review and meta-analysis will be extracted from published studies. Study results will be disseminated by publishing our findings in a peer-reviewed journal.
引用
收藏
页数:4
相关论文
共 37 条
  • [1] [Anonymous], 2022, Cochrane Handbook for Systematic Reviews of Interventions Version 6.3
  • [2] Gray matter abnormalities in Major Depressive Disorder: A meta-analysis of voxel based morphometry studies
    Bora, Emre
    Fornito, Alex
    Pantelis, Christos
    Yuecel, Murat
    [J]. JOURNAL OF AFFECTIVE DISORDERS, 2012, 138 (1-2) : 9 - 18
  • [3] Effect of antidepressive therapy on retinal contrast processing in depressive disorder
    Bubl, Emanuel
    Ebert, Dieter
    Kern, Elena
    van Elst, Ludger Tebartz
    Bach, Michael
    [J]. BRITISH JOURNAL OF PSYCHIATRY, 2012, 201 (02) : 151 - 158
  • [4] Seeing Gray When Feeling Blue? Depression Can Be Measured in the Eye of the Diseased
    Bubl, Emanuel
    Kern, Elena
    Ebert, Dieter
    Bach, Michael
    van Elst, Ludger Tebartz
    [J]. BIOLOGICAL PSYCHIATRY, 2010, 68 (02) : 205 - 208
  • [5] Spectral domain optical coherence tomography - Ultra-high speed, ultra-high resolution ophthalmic imaging
    Chen, TC
    Cense, B
    Pierce, MC
    Nassif, N
    Park, BH
    Yun, SH
    White, BR
    Bouma, BE
    Tearney, GJ
    de Boer, JF
    [J]. ARCHIVES OF OPHTHALMOLOGY, 2005, 123 (12) : 1715 - 1720
  • [6] Retinal structural changes in mood disorders: The optical coherence tomography to better understand physiopathology?
    Clemence-Fau, Martine
    Schwan, Raymund
    Angioi-Duprez, Karine
    Laprevote, Vincent
    Schwitzer, Thomas
    [J]. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2021, 108
  • [7] Improved signal-to-noise ratio in spectral-domain compared with time-domain optical coherence tomography
    de Boer, JF
    Cense, B
    Park, BH
    Pierce, MC
    Tearney, GJ
    Bouma, BE
    [J]. OPTICS LETTERS, 2003, 28 (21) : 2067 - 2069
  • [8] Bias in meta-analysis detected by a simple, graphical test
    Egger, M
    Smith, GD
    Schneider, M
    Minder, C
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 1997, 315 (7109): : 629 - 634
  • [9] Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019
    Ferrari, Alize J.
    Santomauro, Damian F.
    Herrera, Ana M. Mantilla
    Shadid, Jamileh
    Ashbaugh, Charlie
    Erskine, Holly E.
    Charlson, Fiona J.
    Degenhardt, Louisa
    Scott, James G.
    McGrath, John J.
    Allebeck, Peter
    Benjet, Corina
    Breitborde, Nicholas J. K.
    Brugha, Traolach
    Dai, Xiaochen
    Dandona, Lalit
    Dandona, Rakhi
    Fischer, Florian
    Haagsma, Juanita A.
    Maria Haro, Josep
    Kieling, Christian
    Knudsen, Ann Kristin Skrindo
    Kumar, G. Anil
    Leung, Janni
    Majeed, Azeem
    Mitchell, Philip B.
    Moitra, Modhurima
    Mokdad, Ali H.
    Molokhia, Mariam
    Patten, Scott B.
    Patton, George C.
    Phillips, Michael R.
    Soriano, Joan B.
    Stein, Dan J.
    Stein, Murray B.
    Szoeke, Cassandra E., I
    Naghavi, Mohsen
    Hay, Simon, I
    Murray, Christopher J. L.
    Vos, Theo
    Whiteford, Harvey A.
    [J]. LANCET PSYCHIATRY, 2022, 9 (02): : 137 - 150
  • [10] Mapping Retinal Abnormalities in Psychosis: Meta-analytical Evidence for Focal Peripapillary and Macular Reductions
    Gonzalez-Diaz, Jairo M.
    Radua, Joaquim
    Sanchez-Dalmau, Bernardo
    Camos-Carreras, Anna
    Zamora, Diana C.
    Bernardo, Miquel
    [J]. SCHIZOPHRENIA BULLETIN, 2022, 48 (06) : 1194 - 1205